ANI Pharmaceuticals, Inc. (ANIP) vs Septerna Inc (SEPN)

A side-by-side comparison of ANI Pharmaceuticals, Inc. and Septerna Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
ANI Pharmaceuticals, Inc. logo
ANIP
ANI Pharmaceuticals, Inc.
$1.63B
$71.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Septerna Inc logo
SEPN
Septerna Inc
$1.61B
$35.67HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ANIP vs SEPN

growth of $100 · dividends reinvested · last 2y
ANIP +22.4% (+10.7%/yr)SEPN +77.0% (+33.0%/yr)SEPN compounded faster over this window
50100150200Start $10020252026$122$177
ANIP SEPN

ANIP vs SEPN: by the numbers

  • •ANIP is the larger company ($1.63B vs $1.61B market cap).
  • •ANIP is profitable (10.82% net margin) while SEPN runs a net loss (-24.51%).

Metrics side by side

Valuation

MetricANIPSEPN
P/E ratio15.45N/A
Forward P/E7.71N/A
P/S ratio1.6616.26
P/B ratio2.724.16
EV / EBITDA6.76N/A
FCF yieldN/A6.54%

Profitability

MetricANIPSEPN
Gross margin51.01%99.57%
Operating margin15.35%-175.83%
Net margin10.82%-24.51%
ROE17.72%-6.27%
ROIC9.26%-8.93%

Growth (annualized)

MetricANIPSEPN
Revenue CAGR (5Y)35.61%N/A
Total return CAGR (5Y)16.86%N/A

Frequently asked

Is ANIP or SEPN more profitable?
ANIP runs the higher net margin — ANIP at 10.82% versus SEPN at -24.51%.

Go deeper

Full ANIP analysisFull SEPN analysisInteractive comparison tool

Dig into the metrics

ANI Pharmaceuticals P/E ratioANI Pharmaceuticals ROESepterna ROEANI Pharmaceuticals operating marginSepterna operating marginANI Pharmaceuticals revenue growthSepterna revenue growthANI Pharmaceuticals free cash flowSepterna free cash flow

ANI Pharmaceuticals & Septerna appear in these rankings

Fastest Revenue Growth StocksHighest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.